Duke University Hospital Emergency Department
Durham, North Carolina, 27710, United States
NCT Number: NCT04290741
The purpose of this project is to determine the feasibility, acceptability and effectiveness of acupuncture in the Emergency Department (ED) for treating acute musculoskeletal pain. The overall goal is to reduce acute and subacute opioid use by improving acute pain, anxiety and disability with non-pharmacologic treatment options at a critical entry point for patients into the healthcare system. This full-scale randomized controlled trial (RCT) has been statistically powered to test the effectiveness of ED-based acupuncture for both one-hour (Stage 1) and one-month (Stage 2) pain reduction outcomes. The feasibility will be assessed based on patient recruitment and retention rates, while the acceptability will be assessed using patient reported outcomes and qualitative semi-structured interviews.
Stage 1 is a 2-phase study design. Phase (1): Enrolled subjects will be randomized to auricular (ear) acupuncture, peripheral acupuncture, or the control group receiving no acupuncture. Subjects assigned to an acupuncture arm will receive information and access to acupuncture in an outpatient clinic for the 4 weeks following ED visit. Subjects may also have a blood draw for biomarker analysis during their ED visit. A planned interim analysis of the first 60 patients (2/3 of the Phase 1 arm completed) will be completed to select the more effective and/or acceptable arm for Phase 2. At interim analysis, it was determined by the DSMB that neither arm was superior, so the recommendation was to continue Stage 1 Phase 2 unchanged with 3 arms. Stage 1 is complete, and we will proceed with Stage 2 powered to the 4-week pain score outcome. Stage 2 will proceed with the same procedures as stage 1, only powered to a different outcome.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Durham, North Carolina, 27710, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Placement of needles based on battlefield acupuncture protocol which includes up to 5 sites on each ear to treat pain.
Placement of needles in up to 30 specific sites in the head, neck, arms from the shoulders to the hands, and legs from the knees to the feet
Time frame: ED pre-acupuncture (baseline); ED post-acupuncture (up to 1 hour); 2 and 4 weeks post discharge
11-point Numeric Rating Scale (NRS) for current pain
Time frame: Post implementation, up to 6 weeks
Time frame: Post implementation, up to 6 weeks
Time frame: Post implementation, up to 6 weeks
Time frame: Post implementation, up to 6 weeks
Likert-scale, agree disagree
Time frame: 4 weeks post discharge
Time frame: Post implementation, up to 2 weeks
Time frame: ED pre-acupuncture (baseline); ED post-acupuncture (up to 1 hour); 2 and 4 weeks post discharge
PROMIS-29
Time frame: ED pre-acupuncture (baseline); ED post-acupuncture (up to 1 hour); 2 and 4 weeks post discharge
Neuro-QoL
Time frame: Up to one year post ED visit
Time frame: Up to three months post ED visit
Time frame: Post ED acupuncture session, up to 1 hour
Duke University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01538745
Abdomen, Acute, Abdominal Pain
San Antonio, Texas, United States
View Trial DetailsNCT04724694
Chronic Pain, Muscular Diseases
Buffalo, New York, United States
View Trial DetailsNCT07274540
Arm Injuries, Cumulative Trauma Disorders
Istanbul, Beykoz, Turkey (Türkiye)
View Trial DetailsNCT04763876
Adverse Event, Agnosia
El Paso, Texas, United States
View Trial Details